INS and type 2 diabetes mellitus: Increased insulin utilization to treat type II diabetes mellitus (DM) can lead to dysfunction of the pancreatic β-cells and their subsequent destruction, which can ultimately lead to a decrease and cessation of insulin production and secretion.